Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'BM 06.022' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 41 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bookstein, JJ; Bookstein, FL
      Pulse-spray thrombolysis with reteplase: Optimization and comparison with tPA in a rabbit model

      JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    2. Armstrong, PW; Collen, D
      Fibrinolysis for acute myocardial infarction - Current status and new horizons for pharmacological reperfusion, Part 1

      CIRCULATION
    3. Cohen, A
      Pharmacokinetics of the recombinant thrombolytic agents - What is the clinical significance of their different pharmacokinetic parameters?

      BIODRUGS
    4. Martin, U; Kaufmann, B; Neugebauer, G
      Current clinical use of reteplase for thrombolysis - A pharmacokinetic-pharmacodynamic perspective

      CLINICAL PHARMACOKINETICS
    5. HANNA GP; SMALLING RW
      THERAPY WITH THROMBOLYTIC AGENTS IN CORONARY-ARTERY DISEASE

      Current opinion in cardiology
    6. MOSER M; KOHLER B; SCHMITTNER M; BODE C
      RECOMBINANT PLASMINOGEN ACTIVATORS - A COMPARATIVE REVIEW OF THE CLINICAL-PHARMACOLOGY AND THERAPEUTIC USE OF ALTEPLASE AND RETEPLASE

      Biodrugs
    7. FISCHER S; KOHNERT U
      MAJOR MECHANISTIC DIFFERENCES EXPLAIN THE HIGHER CLOT LYSIS POTENCY OF RETEPLASE OVER ALTEPLASE - LACK OF FIBRIN BINDING IS AN ADVANTAGE FOR BOLUS APPLICATION OF FIBRIN-SPECIFIC THROMBOLYTICS

      Fibrinolysis & proteolysis
    8. GRUNEWALD M; MULLER M; ELLBRUCK D; OSTERHUES H; KOCHS M; MOHREN M; SCHIRMER G; ZIESCHE S; GULOGLU A; BOCK R; SEIFRIED E
      DOUBLE-BOLUS VERSUS SINGLE-BOLUS THROMBOLYSIS WITH RETEPLASE FOR ACUTE-MYOCARDIAL-INFARCTION - A PHARMACOKINETIC AND PHARMACODYNAMIC STUDY

      Fibrinolysis & proteolysis
    9. BODE C; PETER K; NORDT TK; RUEF J; SMALLING RW; KUBLER W
      PHARMACOLOGY AND CLINICAL EFFICACY OF RETEPLASE

      Fibrinolysis & proteolysis
    10. HAMPTON JR
      RETEPLASE MORTALITY STUDIES

      Fibrinolysis & proteolysis
    11. CHEN BP; CHOW MSS; KLUGER J
      PERSPECTIVES ON CURRENT, FUTURE THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION

      Formulary
    12. OBERG KC; CANNON CP; PLUTZKY J
      FOCUS ON RETEPLASE - A NEWLY APPROVED 3RD-GENERATION THROMBOLYTIC AGENT FOR THE TREATMENT OF ACUTE MYOCARDIAL-INFARCTION

      Formulary
    13. SMALLING RW
      A FRESH LOOK AT THE MOLECULAR PHARMACOLOGY OF PLASMINOGEN ACTIVATORS - FROM THEORY TO TEST-TUBE TO CLINICAL OUTCOMES

      American journal of health-system pharmacy
    14. MULDER M; KOHNERT U; FISCHER S; VANHINSBERGH VWM; VERHEIJEN JH
      THE INTERACTION OF RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND RECOMBINANT PLASMINOGEN-ACTIVATOR (R-PA BM-06.022) WITH HUMAN ENDOTHELIAL-CELLS

      Blood coagulation & fibrinolysis
    15. HAMPTON JR
      THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL-INFARCTION

      Cardiovascular drugs and therapy
    16. SMALLING RW
      PHARMACOLOGICAL AND CLINICAL IMPACT OF THE UNIQUE MOLECULAR-STRUCTUREOF A NEW PLASMINOGEN-ACTIVATOR

      European heart journal
    17. BODE C; PETER K; MOSER M; SMALLING RW; WEAVER WD
      CLINICAL-TRIAL RESULTS WITH A NEW PLASMINOGEN-ACTIVATOR

      European heart journal
    18. HAMPTON JR
      THE CONCEPT OF EQUIVALENCE AND ITS APPLICATION TO THE ASSESSMENT OF THROMBOLYTIC EFFECTS

      European heart journal
    19. HANNA GP; SMALLING RW
      RETEPLASE, A NEW 3RD-GENERATION THROMBOLYTIC AGENT

      Medicamentos de actualidad
    20. MARTIN U; KOHNERT U
      PHARMACOKINETIC AND PRECLINICAL STUDIES WITH RETEPLASE

      Medicamentos de actualidad
    21. FISCHER S
      THE MOLECULAR DESIGN OF RETEPLASE

      Medicamentos de actualidad
    22. BODE C; MOSER M; RUEF J; NORDT T; PETER K; KUBLER W; SMALLING RW
      CLINICAL-STUDIES WITH RETEPLASE

      Medicamentos de actualidad
    23. RIJKEN DC; JIE AFH
      INTERACTION OF RETEPLASE WITH HEPARIN - A COMPARISON BETWEEN RETEPLASE AND ALTEPLASE

      Blood coagulation & fibrinolysis
    24. BODE C; GULBA D; HUBER K; RUNGE MS
      NEW APPROACHES IN PLASMINOGEN-ACTIVATOR THERAPY

      Annals of hematology
    25. MARTIN U; KOHNERT U; STERN A; POPP F; FISCHER S
      COMPARISON OF THE RECOMBINANT ESCHERICHIA COLI-PRODUCED PROTEASE DOMAIN OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR WITH ALTEPLASE, RETEPLASE AND STREPTOKINASE IN A CANINE MODEL OF CORONARY-ARTERY THROMBOLYSIS

      Thrombosis and haemostasis
    26. AMSTERDAM EA
      CONTROLLED TRIALS COMPARING RETEPLASE WITH ALTEPLASE AND STREPTOKINASE IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

      Pharmacotherapy
    27. WEAVER WD
      THE ROLE OF THROMBOLYTIC DRUGS IN THE MANAGEMENT OF MYOCARDIAL-INFARCTION - COMPARATIVE CLINICAL-TRIALS

      European heart journal
    28. WEAVER WD
      RESULTS OF THE RAPID-1 AND RAPID-2 THROMBOLYTIC TRIALS IN ACUTE MYOCARDIAL-INFARCTION

      European heart journal
    29. MARTIN U; DOERGE L; STEGMEIER K; MULLERBECKMANN B
      INFLUENCE OF THE DEGREE OF RENAL DYSFUNCTION ON THE PHARMACOKINETIC PROPERTIES OF THE NOVEL RECOMBINANT PLASMINOGEN-ACTIVATOR RETEPLASE IN RATS

      Drug metabolism and disposition
    30. NOBLE S; MCTAVISH D
      RETEPLASE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL EFFICACY IN THE MANAGEMENT OF ACUTE MYOCARDIAL-INFARCTION

      Drugs
    31. BODE C; SMALLING RW; BERG G; BURNETT C; LORCH G; KALBFLEISCH JM; CHERNOFF R; CHRISTIE LG; FELDMAN RL; SEALS AA; WEAVER WD
      RANDOMIZED COMPARISON OF CORONARY THROMBOLYSIS ACHIEVED WITH DOUBLE-BOLUS RETEPLASE (RECOMBINANT PLASMINOGEN-ACTIVATOR) AND FRONT-LOADED, ACCELERATED ALTEPLASE (RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR) IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

      Circulation
    32. MARTIN U; DORGE L; FISCHER S
      COMPARISON OF DESULFATOHIRUDIN (REVASC) AND HEPARIN AS ADJUNCTS TO THROMBOLYTIC THERAPY WITH RETEPLASE IN A CANINE MODEL OF CORONARY-THROMBOSIS

      British Journal of Pharmacology
    33. SMALLING RW
      MOLECULAR-BIOLOGY OF PLASMINOGEN ACTIVATORS - WHAT ARE THE CLINICAL IMPLICATIONS OF DRUG DESIGN

      The American journal of cardiology
    34. BODE C; NORDT TK; PETER K; SMALLING RW; RUNGE MS; KUBLER W
      PATENCY TRIALS WITH RETEPLASE (R-PA) - WHAT DO THEY TELL US

      The American journal of cardiology
    35. VERSTRAETE M
      THE FIBRINOLYTIC SYSTEM - FROM PETRI DISHES TO GENETIC-ENGINEERING

      Thrombosis and haemostasis
    36. BODE C; KOHLER B; SMALLING RW; RUNGE MS
      RETEPLASE (R-PA) - A NOVEL RECOMBINANT PLASMINOGEN-ACTIVATOR

      Fibrinolysis
    37. SMALLING RW; BODE C; KALBFLEISCH J; SEN S; LIMBOURG P; FORYCKI F; HABIB G; FELDMAN R; HOHNLOSER S; SEALS A; CALIFF R; GUERCI A; SCHROEDER R; TOPOL E; DEBOWEY D; LINDERER T; LOSCALZO J; ODENHEIMER D; BOEM E; BAUMANN H; GRIES A; KOHLER B; FREITAG M; BERG G; SCHREIBER P; ROTH E; SCHMALZ W; DICK R; KLINGENHEBEN T; MAISCH B; GEHRKE D; HAUPTMANN K; SCHWARZBACH F; ALBRECHT P; STEINBECK G; BLUMENSTEIN M; BEUCKELMANN D; REITH R; NEUHOLD H; BERGER H; KASEL M; KASKI J; RUSTIGE J; SCHREIBER Y; SEKKAL M; LEHMKUHL; ZANDER M; ZAHN R; KOSER R; SEIDL H; ASTHEIMER W; HAUER B; LOTTER R; ZIMMER; SCHWARZ A; FIEHRING H; PECH H; SCHULZ O; MENGER J; ZIMMERMANN F; GOEDICKE W; KREUZER H; BUCHWALD B; RAB J; FOALE R; PROBST P; KRATOCHWILL C; LAGGNER A; SCHREIBER W; ALTMANN E; GRAF A; SPRANGER C; GULBA D; GUNTHER C; SLAGLE R; BREWER D; MCENTEE C; OKADA R; SPAIN M; WATERS J; LUCENTA B; ROSS W; COOPER J; GHITIS A; FRIEDMAN M; HIGGINS J; LIM M; WAGNER V; BLACK S; DEWALD S; FUENTES F; ANDERSON H; HEIBIG J; LI G; SCHROTH G; ADYANTHAYA A; WILLERSON J; HESS M; MOLKE K; UNDERWOOD C; WEIGELT L; MANN D; STEIN B; CHEIRIF J; JEROUDI M; MICKELSON J; RODRIQUEZ R; HILDNER F; STANDLEY M; CRAGGS L; BAKER S; GILMOUR K; BAKER R; HARTLEY J; AMSTERDAM E; MARTSCHINSKE R; KRSTICH K; MARTSCHINSKE R; KARLSBERG R; BHATIA S; MURPHY F; STONE J; CHERNOFF R; WEINER R; BHARK P; RUDY S; DONAHUE C; HARLAMERT E; BUGNI W; EDMANDS R; HAHN R; HAZLETT S; MACPHAIL B; MCGOFF J; MANALO E; MELDAHL R; PESKOE S; SHARP S; STANLEY K; VENTURINI M; WEINBERG B; ZIPERMAN D; ADAMS C; FISHER B; THADANI U; OLSON E; HARVEY J; SCHECHTER E; SCHMIDT D; TURNER J; MORRIS R; BERMAN P; ALI A; BAIG M; REDDY D; GONZALEZ D; LIPETZ D; LEIMGRUBER P; SUTHERLAND K; JUDGE T; HINNEN M; GOODMAN G; GOLDBERG H; FUHS B; KATZ G; SAVRAN S; FISHER M; VANVIG S; KIRCHOFF S; RAMASWAMY K; LOSORDO D; KEANE S; AQUINO V; BHATIA H; COLEMAN G; AGUSALA R; AMELL J; LIEBER I; MOORE C; POLLO W; PEREZ G; RAO M; SHENOY V; DIPPEL J; GOTTLIEB D; GREEN B; HANSEN D; WILLIAMS T; BURNETT C; KREISMAN K; BROWN T; WILLIAMS T; LASKEY W; HERRMANN H; KUSSMAUL W; HIRSHFELD J; KROL J; WORLEY S; GAULT J; GENTZLER R; SMITH I; SLOVAK J; SUPPLE E; ANDERSON R; SMALL R; CLARK N; IBARRA J; CANOSA R; CORBALLY F; DERON S; LOSS D; CLARK K; DAMIANO J; LEAMAN P; LUCAS R; MAYBERRY J; MAZDA R; WINIARSKI G; TUZI J; ANDERSON E; MEAD R; SMITH N; WINKLE R; RUDER M; TITUS C; BENOTTI J; DAVE R; PENDLETON J; SHARMA G; VITA J; DALEY W; LAPSLEY D; HWANG M; CARROLL R; SUMIDA C; CALLAHAN J; ELSHERIF N; BEKHEIT S; KHAN R; SILLS J
      MORE RAPID, COMPLETE, AND STABLE CORONARY THROMBOLYSIS WITH BOLUS ADMINISTRATION OF RETEPLASE COMPARED WITH ALTEPLASE INFUSION IN ACUTE MYOCARDIAL-INFARCTION

      Circulation
    38. VERSTRAETE M; LIJNEN HR
      NOVEL THROMBOLYTIC AGENTS

      Cardiovascular drugs and therapy
    39. NEUHAUS KL; VONESSEN R; VOGT A; TEBBE U; RUSTIGE J; WAGNER HJ; APPEL KF; STIENEN U; KONIG R; MEYERSABELLEK W
      DOSE-FINDING WITH A NOVEL RECOMBINANT PLASMINOGEN-ACTIVATOR (BM-06.022) IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THE GERMAN RECOMBINANT PLASMINOGEN-ACTIVATOR STUDY

      Journal of the American College of Cardiology
    40. ZEYMER U; NEUHAUS KL
      DEVELOPMENT OF NEW FIBRINOLYTIC AGENTS

      Herz
    41. TEBBE U; VONESSEN R; SMOLARZ A; LIMBOURG P; ROX J; RUSTIGE J; VOGT A; WAGNER J; MEYERSABELLEK W; NEUHAUS KL
      OPEN, NONCONTROLLED DOSE-FINDING STUDY WITH A NOVEL RECOMBINANT PLASMINOGEN-ACTIVATOR (BM 06.022) GIVEN AS A DOUBLE BOLUS IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

      The American journal of cardiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/21 alle ore 19:40:18